Trex Medical signs deal to buy XRE
Trex Medical continues to roll on the acquisition road. The holdingcompany for x-ray firms Lorad and Bennett X-Ray last week signeda letter of intent to buy XRE of Littleton, MA, a vendor of cardiaccath labs and angiography suites. XRE will give Trex
Trex Medical continues to roll on the acquisition road. The holdingcompany for x-ray firms Lorad and Bennett X-Ray last week signeda letter of intent to buy XRE of Littleton, MA, a vendor of cardiaccath labs and angiography suites.
XRE will give Trex Medical a presence in the upper end of x-rayto complement the positions Lorad and Bennett have in basic x-rayand mammography. When the deal is completed, XRE systems willbe sold through qualified Bennett and Lorad dealers, accordingto Trex Medical president and CEO Hal Kirshner. XRE also suppliescardiac cath labs to Philips on an OEM basis and had revenuesof $28.6 million last year.
Further synergies may come from the integration of Trex Medical'shigh-end digital detector technology that is under development.For example, a flat-panel digital detector could be substitutedfor the image intensifier on an XRE cardiac cath lab, accordingto Kirshner.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
